Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.

Price MA, Rida W, Kilembe W, Karita E, Inambao M, Ruzagira E, Kamali A, Sanders EJ, Anzala O, Hunter E, Allen S, Edward VA, Wall KM, Tang J, Fast PE, Kaleebu P, Lakhi S, Mutua G, Bekker LG, Abu-Baker G, Tichacek A, Chetty P, Latka MH, Maenetje P, Makkan H, Kibengo F, Priddy F, Gilmour J.

J Infect Dis. 2019 Jul 2;220(3):432-441. doi: 10.1093/infdis/jiz127.

2.

Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study.

Settergren SK, Mujaya S, Rida W, Kajula LJ, Kamugisha H, Kilonzo Mbwambo J, Kisanga F, Mizinduko MM, Dunbar MS, Mwandalima I, Wazee H, Prieto D, Mullick S, Erie J, Castor D.

PLoS One. 2018 Dec 6;13(12):e0206074. doi: 10.1371/journal.pone.0206074. eCollection 2018.

3.

Pregnancy and HIV Disease Progression in an Early Infection Cohort from Five African Countries.

Wall KM, Rida W, Haddad LB, Kamali A, Karita E, Lakhi S, Kilembe W, Allen S, Inambao M, Yang AH, Latka MH, Anzala O, Sanders EJ, Bekker LG, Edward VA, Price MA.

Epidemiology. 2017 Mar;28(2):224-232. doi: 10.1097/EDE.0000000000000590.

4.

Efficacy and Safety of 'Fixed Dose' versus 'Loose' Drug Regimens for Treatment of Pulmonary Tuberculosis in Two High TB-Burden African Countries: A Randomized Controlled Trial.

Aseffa A, Chukwu JN, Vahedi M, Aguwa EN, Bedru A, Mebrahtu T, Ezechi OC, Yimer G, Yamuah LK, Medhin G, Connolly C, Rida W, Aderaye G, Zumla AI, Onyebujoh PC; 4FDC Study Group.

PLoS One. 2016 Jun 20;11(6):e0157434. doi: 10.1371/journal.pone.0157434. eCollection 2016.

5.

Corrigendum: T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O'Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatherill M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H.

Nat Commun. 2016 May 6;7:11633. doi: 10.1038/ncomms11633. No abstract available.

6.

T-cell activation is an immune correlate of risk in BCG vaccinated infants.

Fletcher HA, Snowden MA, Landry B, Rida W, Satti I, Harris SA, Matsumiya M, Tanner R, O'Shea MK, Dheenadhayalan V, Bogardus L, Stockdale L, Marsay L, Chomka A, Harrington-Kandt R, Manjaly-Thomas ZR, Naranbhai V, Stylianou E, Darboe F, Penn-Nicholson A, Nemes E, Hatherill M, Hussey G, Mahomed H, Tameris M, McClain JB, Evans TG, Hanekom WA, Scriba TJ, McShane H.

Nat Commun. 2016 Apr 12;7:11290. doi: 10.1038/ncomms11290. Erratum in: Nat Commun. 2016 May 06;7:11633.

7.

WHO's new guidelines for antiretroviral treatment.

Fast PE, Price MA, Rida WN, Kamali A, Karita E; International AIDS Vaccine Initiative (IAVI) African Early Infection Research Group.

Lancet. 2013 Nov 30;382(9907):1778-9. doi: 10.1016/S0140-6736(13)62539-8. No abstract available.

PMID:
24290585
8.

Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa.

Amornkul PN, Karita E, Kamali A, Rida WN, Sanders EJ, Lakhi S, Price MA, Kilembe W, Cormier E, Anzala O, Latka MH, Bekker LG, Allen SA, Gilmour J, Fast PE; IAVI Africa HIV Prevention Partnership.

AIDS. 2013 Nov 13;27(17):2775-86. doi: 10.1097/QAD.0000000000000012.

9.

Reduced antituberculosis drug concentrations in HIV-infected patients who are men or have low weight: implications for international dosing guidelines.

McIlleron H, Rustomjee R, Vahedi M, Mthiyane T, Denti P, Connolly C, Rida W, Pym A, Smith PJ, Onyebujoh PC.

Antimicrob Agents Chemother. 2012 Jun;56(6):3232-8. doi: 10.1128/AAC.05526-11. Epub 2012 Mar 12.

10.

Identifying at-risk populations in Kenya and South Africa: HIV incidence in cohorts of men who report sex with men, sex workers, and youth.

Price MA, Rida W, Mwangome M, Mutua G, Middelkoop K, Roux S, Okuku HS, Bekker LG, Anzala O, Ngugi E, Stevens G, Chetty P, Amornkul PN, Sanders EJ.

J Acquir Immune Defic Syndr. 2012 Feb 1;59(2):185-93. doi: 10.1097/QAI.0b013e31823d8693.

PMID:
22227488
11.

AIDS vaccines and preexposure prophylaxis: is synergy possible?

Excler JL, Rida W, Priddy F, Gilmour J, McDermott AB, Kamali A, Anzala O, Mutua G, Sanders EJ, Koff W, Berkley S, Fast P.

AIDS Res Hum Retroviruses. 2011 Jun;27(6):669-80. doi: 10.1089/AID.2010.0206. Epub 2010 Dec 16. Review.

12.

Human immunodeficiency virus type 1 elite neutralizers: individuals with broad and potent neutralizing activity identified by using a high-throughput neutralization assay together with an analytical selection algorithm.

Simek MD, Rida W, Priddy FH, Pung P, Carrow E, Laufer DS, Lehrman JK, Boaz M, Tarragona-Fiol T, Miiro G, Birungi J, Pozniak A, McPhee DA, Manigart O, Karita E, Inwoley A, Jaoko W, Dehovitz J, Bekker LG, Pitisuttithum P, Paris R, Walker LM, Poignard P, Wrin T, Fast PE, Burton DR, Koff WC.

J Virol. 2009 Jul;83(14):7337-48. doi: 10.1128/JVI.00110-09. Epub 2009 May 13.

13.

Modeling the population level effects of an HIV-1 vaccine in an era of highly active antiretroviral therapy.

Rida W, Sandberg S.

Bull Math Biol. 2009 Apr;71(3):648-80. doi: 10.1007/s11538-008-9375-5. Epub 2009 Feb 12.

PMID:
19214640
14.

A strategy for accelerating the development of preventive AIDS vaccines.

Excler JL, Rida W, Priddy F, Fast P, Koff W.

AIDS. 2007 Nov 12;21(17):2259-63. Review. No abstract available.

PMID:
18090273
15.

Lot consistency as an equivalence problem.

Lachenbruch PA, Rida W, Kou J.

J Biopharm Stat. 2004 May;14(2):275-90.

PMID:
15206526
16.

Statistical issues for HIV surrogate endpoints: point/counterpoint. An NIAID workshop.

Albert JM, Ioannidis JP, Reichelderfer P, Conway B, Coombs RW, Crane L, Demasi R, Dixon DO, Flandre P, Hughes MD, Kalish LA, Larntz K, Lin D, Marschner IC, Muñoz A, Murray J, Neaton J, Pettinelli C, Rida W, Taylor JM, Welles SL.

Stat Med. 1998 Nov 15;17(21):2435-62.

PMID:
9819838
17.

Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations.

Longini IM Jr, Sagatelian K, Rida WN, Halloran ME.

Stat Med. 1998 May 30;17(10):1121-36. Erratum in: Stat Med 1999 Apr 15;18(7):890.

PMID:
9618773
18.

Intermediate-size trials for the evaluation of HIV vaccine candidates: a workshop summary.

Rida W, Fast P, Hoff R, Fleming T.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Nov 1;16(3):195-203.

PMID:
9390572
19.

HIV vaccines.

Ellenberg SS, Rida WN.

Lancet. 1997 Feb 1;349(9048):361. No abstract available.

PMID:
9024406
20.

Assessing the effect of HIV vaccination on infectiousness.

Rida WN.

Stat Med. 1996 Nov 15-30;15(21-22):2393-404; discussion 2405-12.

PMID:
8931209
21.

Impact of improved treatment of sexually transmitted disease on HIV infection.

Foulkes MA, Rida WN, Hoff R.

Lancet. 1995 Oct 28;346(8983):1158. No abstract available.

PMID:
7475616
22.

AIDS: modeling epidemic control.

Rida W, Fast P, Hoff R, Barker L.

Science. 1995 Mar 3;267(5202):1251-2; author reply 1252-3. No abstract available.

PMID:
7871415
23.

Statistical issues in the design of HIV vaccine trials.

Schaper C, Fleming TR, Self SG, Rida WN.

Annu Rev Public Health. 1995;16:1-22. Review.

PMID:
7639865
24.

Some statistical issues in HIV vaccine trials.

Rida WN, Lawrence DN.

Stat Med. 1994 Oct 15-30;13(19-20):2155-77.

PMID:
7846417
25.

HIV vaccine trials: some design issues including sample size calculation.

Dixon DO, Rida WN, Fast PE, Hoth DF.

J Acquir Immune Defic Syndr. 1993 May;6(5):485-96.

PMID:
8483112
26.

Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.

Leikin SL, Gallagher D, Kinney TR, Sloane D, Klug P, Rida W.

Pediatrics. 1989 Sep;84(3):500-8.

PMID:
2671914
27.

Automated sphygmomanometer in spinal cord injured patients during head-up tilt: an evaluation.

Hammond MC, Hinde JD, Rida W.

Arch Phys Med Rehabil. 1987 Jul;68(7):430-3.

PMID:
3606366
28.

Continuous noninvasive monitoring of cardiac output with esophageal Doppler ultrasound during cardiac surgery.

Mark JB, Steinbrook RA, Gugino LD, Maddi R, Hartwell B, Shemin R, DiSesa V, Rida WN.

Anesth Analg. 1986 Oct;65(10):1013-20.

PMID:
3530048

Supplemental Content

Support Center